Suzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
I have been asked several times this year whether covering a market that operates partly outside regulation amounts to endorsing it. It does not, and the alternative — declining to report on something because reporting might dignify it — leaves the field to people with an interest in what you believe. A market this size is going to be described by somebody. It may as well be described accurately.
In this number, 60 pieces across 8 departments, with 110 further dispatches filed from the newsroom and 31 contributors on the page. We lead with Harriet Oduya on The regain trajectories, arm by arm, with the estimands named and set beside it Delphine Ruzek in Patient Notes. Part 5 of The Stopping Question continues on the inside pages.
I keep returning to the observation that this is a manufacturing story before it is a clinical one. The molecules were characterised twenty years ago and the pharmacology is not seriously contested. What is contested — potency, sterility, provenance, price, availability — all happens between a reactor and a vial, and that is a beat with documents, suppliers, freight and margin in it rather than a beat with opinions.
If you think a sentence in this issue has outrun its evidence, say so. Roughly one correction in five that we publish arrives from a reader, which is a better hit rate than our own desk manages.
Delayed emptying explains some of this, and not all of it
A single drug producing both constipation and diarrhoea looks contradictory until the motility data is read properly.
Priya Ramanathan, PharmD
1642 words
When a symptom is information and when it is noise
The practice is near-universal, clinically sensible, and supported by observational data rather than randomised comparison. We…
Marguerite Vasseur
1283 words
The limits of mechanism: why receptor data will not tell you who responds
Receptor pharmacology is strong on average effects and almost silent on individual variation. That gap is where most reader…
Marguerite Vasseur
1131 words
Antiemetics, laxatives and the thin literature underneath them
Constipation is the most tractable of the effects and the most consistently under-managed.
Yuki Morishita
2610 words
The eighteenth month, and the conversation that should have happened in the third
The dose-response curve in this class flattens near its top. That has direct consequences for whether the final rung is worth…
Delphine Ruzek
1276 words
Holding a dose is a decision, not a failure
Nausea and gastric delay attenuate over weeks at an unchanged dose. That single physiological fact is the entire justification…
Marguerite Vasseur
1548 words
What the trials counted as intolerance
An effect is dose-limiting when it prevents adequate intake, prevents normal activity, or produces a risk of its own. Discomfort…
Priya Ramanathan, PharmD
1539 words
Accreditation, scope, and the question nobody asks PeptideMeter
Two signatures — one who performed the work, one who approved its release — are the ordinary regulated convention and are almost…
Mei-Lin Tsou
1800 words
The named comparison we promised two years ago
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in…
Evander Sittig
2058 words
Six words a verification badge would need to mean anything
Every step between the laboratory report and the product page removes information, and the badge is the last step.
Evander Sittig
1598 words
The submitted sample: the weakest link in the whole system
The condition on arrival is recorded by some services and not others, and it is one of the more informative lines in a report.
Noor Haddadin
3017 words
What VendorInvestigate is able to certify about a sealed vial, and what it is not
Every certificate circulating in this market answers a question about molecules. Almost none answers a question about organisms,…
Lucía Berenguer
1691 words
Aggregation: the impurity your chromatogram dissolved before it looked
Deamidation, oxidation, aggregation and hydrolysis account for nearly all of what happens to a peptide over time. Each has a…
Roshan Devakumar
1698 words
What PeptideMeter charges to answer the pyrogen question
The masking phenomenon known as low endotoxin recovery means a formulation can return a clean result while containing endotoxin…
Inés Abernathy
1687 words
A year after stopping: what the trials found at the far end
The variance around the mean regain trajectory is large and unexplained, exactly as it is for the weight loss.
Harriet Oduya
1459 words
Falling ferritin is not always falling iron
Three different explanations for the same abnormal number, and how to tell them apart.
Harriet Oduya
2387 words
Why the bone question is harder than the muscle question
Density is a proxy for strength and an imperfect one, particularly when soft-tissue thickness over the measurement site is…
Marguerite Vasseur
1626 words
Not everybody regains at the same rate, and nobody knows why
What returns, in what order, and how much of the benefit survives.
Jonas Arvelo
1721 words
What the older diet-and-exercise trials found in the hip
A plausible mechanism, a measurable change, and no outcome data. This is what an open question looks like.
Anneke van der Molen
1407 words
Why the recent month counts for half the number
The assay is not the problem. The interpretation of a lagging integral as a current measurement is the problem.
Jonas Arvelo
1372 words
The shortage years, and what they taught about interruption
The trials studied planned withdrawal. Almost nobody stops that way.
Harriet Oduya
2447 words
Tapering: a word borrowed from drugs with withdrawal syndromes
What a slow reduction could plausibly buy, and what it certainly cannot prevent.
Jonas Arvelo
1422 words
A named analyst is the cheapest quality signal in this trade
Two signatures — one who performed the work, one who approved its release — are the ordinary regulated convention and are almost…
Orla McCaffrey
1509 words
What twenty companies say about storage, and what they have measured
A retest date says that material should be re-examined before use. An expiry date says it should not be used. The trade uses the…
Wren Kealoha
2423 words
Chain of custody, in a regulated setting, begins at sampling. Here it begins when the package arrives.
Callum Brathwaite
1921 words
A spectrum is a photograph of an ion, not of a molecule
A brief and unromantic tour of the interface between a liquid sample and a vacuum.
Orla McCaffrey
2088 words
A method is a set of numbers. All of them belong on the certificate.
Column chemistry, particle size and pore diameter determine what the separation is capable of before the gradient is even…
Wren Kealoha
1560 words
When a better instrument changes the answer rather than the confidence
Calibration drift is real, unremarkable, and the reason serious laboratories run internal standards.
Harriet Oduya
1579 words
Three services, one lot, and a spread of two and a half points
Duplicate submissions under different names test within-laboratory repeatability, which is a different quantity from…
Wren Kealoha
2436 words
Why a dead-clean sterile filter can pass pyrogen straight through
Three compendial method families are in routine use and a fourth, based on a recombinant enzyme rather than crab lysate, is now…
Harriet Oduya
1447 words
Load, not cardio: the distinction the general advice keeps losing
Mass and function are different endpoints and training affects them differently. Most coverage treats them as one.
Héctor Valmorida
1861 words
Two sessions a week, and the evidence behind the prescription
The older-adult diet-and-exercise trials are the closest analogue to rapid pharmacological weight loss, and they are twenty…
Delphine Ruzek
2637 words
Why your laboratory interval differs from the one in the textbook
The arithmetic of the reference change value, worked for the analytes that matter here.
Priya Ramanathan, PharmD
1817 words
Tolerability is the ceiling, and the ceiling is personal
An effect is dose-limiting when it prevents adequate intake, prevents normal activity, or produces a risk of its own. Discomfort…
Gabriel Ntonga
1545 words
Micronutrient monitoring: which panel, how often, and on whose evidence
A monitoring schedule requires evidence about incidence. For this population, that evidence does not exist.
Tamsin Okonjo
1582 words
Which results are findings and which are consequences of the weight loss
The estimated glomerular filtration rate is calculated from creatinine, creatinine comes from muscle, and muscle mass is…
Tamsin Okonjo
1851 words
The insulin injection-technique literature is large, well conducted and directly transferable on questions of depth and tissue.…
Perpetua Nwachukwu
2704 words
Sarcopenia is a diagnosis, not a synonym for losing lean mass
Almost every practical recommendation in circulation was established in a population that does not resemble the people now…
Delphine Ruzek
1801 words
A design note on withdrawal trials, and why the run-in matters
The regain trajectories, arm by arm, with the estimands named.
Harriet Oduya
2913 words
Maintenance dosing: what is licensed, what is practised, and what is evidenced
Every withdrawal trial compared full dose against nothing. The clinically interesting comparison — full dose against a reduced…
Teodor Lindqvist
1672 words
How a claim degrades between the bench and the listing
The Journal does not treat a badge as evidence and states so wherever it reports one.
Sunniva Ørstavik
1729 words
The supply gap as a clinical event
The trials studied planned withdrawal. Almost nobody stops that way.
Harriet Oduya
1806 words
Chain of custody, and where it begins
What a laboratory can and cannot know about the provenance, storage history and representativeness of what lands on its bench.
Ruslan Yevtushenko
1617 words
A tested vial is evidence about a vial
Every third-party report in this market describes a sample somebody chose to send. That choice is outside the laboratory’s…
Ruslan Yevtushenko
3038 words
What a split-sample exercise can establish, and what it cannot
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in…
Sunniva Ørstavik
2033 words
Side effects, cost, supply, target: four reasons with four trajectories
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
Imogen Thackeray
1656 words
How a correct calculation becomes a wrong dose
We have catalogued what readers report, ranked by the size of the dosing error each produces.
Lucía Berenguer
1646 words
Storage after reconstitution, and the evidence behind the numbers
Sharps disposal is a legal obligation in most jurisdictions and a safety obligation everywhere. Household waste is not a route.
Lucía Berenguer
1616 words
Five lines that would change what a certificate is worth
None of what this piece asks for is commercially sensitive, and all of it is already known to whoever released the batch.
Félix Oyarzún
1812 words
A few hundred participants carry the whole body-composition argument
What was pre-specified, what was exploratory, and what was calculated afterwards by people who did not run the trial.
Félix Oyarzún
1447 words
Turnaround, cost and accreditation across the services this trade relies on
Endotoxin is the more tractable of the two questions, and a kinetic chromogenic determination is neither slow nor exotic. It is…
Lucía Berenguer
2353 words
Vitamin D, adiposity, and a volume-of-distribution problem
Reduced intake is a plausible mechanism for deficiency. Reduced absorption is not, and the two are conflated in most of the…
Lucía Berenguer
1575 words
The 0.22 micron filter does the work, and it is the last line
Bioburden entering the filter, filter integrity, environmental monitoring and aseptic process simulation are the four pillars.…
Callum Brathwaite
1900 words
When a symptom is information and when it is noise
A dose held long enough stops being a pause and becomes a maintenance decision. That transition is rarely made explicitly.
Héctor Valmorida
1453 words
Do you need the top of the ladder?
The dose-response curve in this class flattens near its top. That has direct consequences for whether the final rung is worth…
Delphine Ruzek
1807 words
The incidence tables, read line by line
Trial adverse-event tables count episodes reported to a study nurse. They are the best data we have and they systematically…
Priya Ramanathan, PharmD
1271 words
Six things incretin pharmacology cannot currently predict
Receptor pharmacology is strong on average effects and almost silent on individual variation. That gap is where most reader…
Priya Ramanathan, PharmD
1320 words
How a correct calculation becomes a wrong dose
A pharmacist catches most of these in licensed practice. In this market there is no pharmacist, so the checks have to be…
Héctor Valmorida
2155 words
Delayed emptying explains some of this, and not all of it
What scintigraphy and breath-test studies established about emptying rate, and what they did not.
Priya Ramanathan, PharmD
1443 words
We work through the residual-exposure table so the decision can be made from numbers rather than from feel.
Priya Ramanathan, PharmD
1449 words
Follow the resin, not the catalogue.
The evidence base is thin and the document says so, which is to its credit.
Reported from the sessions, and from the two hours afterwards.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
A proper account of an operation that existed, and of what closing it cost.
Efficacy was never the question in this appraisal. Duration of treatment was.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The evidence base is thin and the document says so, which is to its credit.
The observation that closes a facility is rarely the dramatic one.
Reported from the analysis, not from a warning notice.
The route did not close because of a rule about peptides.
Reported from the sessions, and from the two hours afterwards.
The result is unremarkable. What the report omits is not.
The route did not close because of a rule about peptides.
Reported from the sessions, and from the two hours afterwards.
Reported from the analysis, not from a warning notice.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The observation that closes a facility is rarely the dramatic one.
The document is four pages. Three of them are about dates.
Reported from the analysis, not from a warning notice.
Follow the resin, not the catalogue.
The evidence base is thin and the document says so, which is to its credit.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Efficacy was never the question in this appraisal. Duration of treatment was.
The route did not close because of a rule about peptides.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Reported from the analysis, not from a warning notice.
A proper account of an operation that existed, and of what closing it cost.
Follow the resin, not the catalogue.